88 related articles for article (PubMed ID: 1700908)
1. Demonstration of evolutionary differences between conserved antigenic epitopes in the minor nucleocapsid protein of human papillomavirus types 6b, 16 and 18.
Lehtinen M; Parkkonen P; Niemelä J; Paavonen J
Biochem Biophys Res Commun; 1990 Nov; 172(3):1378-83. PubMed ID: 1700908
[TBL] [Abstract][Full Text] [Related]
2. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.
Rose RC; Bonnez W; Strike DG; Reichman RC
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2725-9. PubMed ID: 2174962
[TBL] [Abstract][Full Text] [Related]
3. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
4. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
6. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.
Dillner L; Heino P; Moreno-Lopez J; Dillner J
J Virol; 1991 Dec; 65(12):6862-71. PubMed ID: 1719234
[TBL] [Abstract][Full Text] [Related]
7. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
Seitz H; Schmitt M; Böhmer G; Kopp-Schneider A; Müller M
Int J Cancer; 2013 Feb; 132(3):E139-48. PubMed ID: 22961598
[TBL] [Abstract][Full Text] [Related]
8. Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.
Jenison SA; Yu XP; Valentine JM; Galloway DA
J Virol; 1989 Feb; 63(2):809-18. PubMed ID: 2463384
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
11. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
12. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
Banks L; Matlashewski G; Pim D; Churcher M; Roberts C; Crawford L
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3081-9. PubMed ID: 2826650
[TBL] [Abstract][Full Text] [Related]
13. Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.
Cason J; Patel D; Naylor J; Lunney D; Shepherd PS; Best JM; McCance DJ
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2973-87. PubMed ID: 2479716
[TBL] [Abstract][Full Text] [Related]
14. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
15. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes.
Kalnin K; Chivukula S; Tibbitts T; Yan Y; Stegalkina S; Shen L; Cieszynski J; Costa V; Sabharwal R; Anderson SF; Christensen N; Jagu S; Roden RBS; Kleanthous H
Vaccine; 2017 Sep; 35(37):4942-4951. PubMed ID: 28778613
[TBL] [Abstract][Full Text] [Related]
17. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.
Jin XW; Cowsert LM; Pilacinski WP; Jenson AB
J Gen Virol; 1989 May; 70 ( Pt 5)():1133-40. PubMed ID: 2471804
[TBL] [Abstract][Full Text] [Related]
18. Sequence variation in the capsid protein genes of human papillomavirus type 16 and type 31.
Icenogle JP; Clancy KA; Lin SY
Virology; 1995 Dec; 214(2):664-9. PubMed ID: 8553573
[TBL] [Abstract][Full Text] [Related]
19. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT
Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983
[TBL] [Abstract][Full Text] [Related]
20. Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16.
Yaegashi N; Xi L; Batra M; Galloway DA
J Infect Dis; 1993 Sep; 168(3):743-7. PubMed ID: 8394865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
